OncoInfluencers to Follow on Social Media: Dr. Guru Sonpavde
We’re pleased to feature Dr. Guru Sonpavde, a leader in drug development and genitourinary oncology, as our next oncoinfluencer.
About Guru Sonpavde
Dr. Guru Sonpavde is the Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida and the Chair of Bladder Cancer Research. He is also a Professor of Medicine at the University of Central Florida. His primary focus is drug development, leading innovative clinical trials on novel immunotherapies and targeted therapies for genitourinary cancers, especially bladder cancer, along with prostate, kidney, penile, and testicular cancers.
Dr. Sonpavde actively shares his insights and updates on cutting-edge clinical trials, emerging drug therapies, and advancements in treating genitourinary cancers on X/Twitter and LinkedIn. His posts highlight the latest developments in immunotherapies, targeted therapies, and patient-centered approaches in oncology care.
Follow Dr. Guru Sonpavde on X/Twitter and LinkedIn to stay informed about his pioneering research and contributions to advancing cancer treatment in the field of genitourinary oncology.
Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023